APLT — Applied Therapeutics Share News
0.000.00%
Last trade - 00:00- $15.67m
- $3.73m
- $0.46m
Applied Therapeutics plummets after FDA declines to approve genetic disease drug
US FDA declines to approve Applied Therapeutics' genetic disease drug (updated)
US FDA declines to approve Applied Therapeutics' genetic disease drug
Applied Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Applied Therapeutics Reports Q3 2024 Financial Results
Brief: Morgan Stanley reports 8% passive stake in Applied Therapeutics Inc
U.S. RESEARCH ROUNDUP-Athira pharma, Lowe's Companies, P&G
U.S. STOCKS ON THE MOVE-United States Steel, Ambac Financial, Apple
U.S. STOCKS ON THE MOVE-Powerfleet, NMI, Vivos Therapeutics
Applied Therapeutics jumps as US FDA cancels panel meeting for genetic disorder drug
Applied Therapeutics rises as US FDA cancels panel meeting for genetic disorder drug
Applied Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Corpay, Epam Systems, MKS Instruments
Applied Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
U.S. STOCKS ON THE MOVE-Eiger BioPharmaceuticals, Reddit, US energy sector
U.S. STOCKS ON THE MOVE-Trump Media & Technology, Semtech, General Dynamics
U.S. STOCKS ON THE MOVE-Guess, Crypto stocks, Liquidia
U.S. STOCKS ON THE MOVE-Gold miners, Spirit Airlines, AT&T
Applied Therapeutics dips after FDA extends review of its genetic disease drug